# A Study of LY4060874 in Healthy Participants

> **NCT06709820** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 121 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** LY4060874
- **DRUG:** LY4060874
- **DRUG:** Placebo
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06709820
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-02
- **Primary completion:** 2026-02-20
- **Final completion:** 2026-02-20
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06709820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06709820, "A Study of LY4060874 in Healthy Participants". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06709820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*